Latest Commercialisation News

Galilee Energy has agreed to sell its Glenaras Gas Project subsidiary to Novus Energy, freeing up capital and management focus to accelerate its US Gulf Coast oil and gas ambitions while retaining a royalty interest in Glenaras.

Iondrive has launched its first five-tonne IONSolv™ production campaign in North America, aiming to produce about 1.4 tonnes of mixed rare earth oxide from recycled permanent magnets by Q4 2026. This milestone bridges lab validation and commercial-scale plans while supporting US supply chain independence.

Papyrus Australia updates its timeline for delivering biodegradable fibre board to TBS Mining Solutions, following trial results that require product refinements. Commercial supply is now expected from November 2026, with acceptance testing due by September.

IperionX plans to relocate its parent company to Texas and list directly on Nasdaq, aligning its corporate structure with its US operations. The appointment of manufacturing veteran Michael J. Loparco aims to bolster the company’s industrial scale-up.

D3 Energy has successfully drilled and intersected gas in the first of two wells at its Nooitgedacht site in South Africa, with the second well underway. The results support expanding helium reserves and future production rights.

Pure Resources has appointed Vice Admiral Michael Noonan AO, retired Chief of the Royal Australian Navy, to its Advisory Board for a year-long term, bolstering its defence strategy and engagement with Australian and allied government agencies.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.

1414 Degrees secured $8.45 million funding and inked major agreements to commercialise its SiNTL battery technology across AI data centres, drones, satellites and defence sectors.

Pure One Corporation has made strides in zero-emission commercial vehicles with new battery-swap and electric models arriving in Australia, backed by a strengthened balance sheet from a $3.5 million tranche of Turquoise Group sale proceeds.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.